Literature DB >> 12602956

A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP.

Yogendra Patel1, Valerie J Gillet, Gianpaolo Bravi, Andrew R Leach.   

Abstract

Three commercially available pharmacophore generation programs, Catalyst/HipHop, DISCO and GASP, were compared on their ability to generate known pharmacophores deduced from protein-ligand complexes extracted from the Protein Data Bank. Five different protein families were included Thrombin, Cyclin Dependent Kinase 2, Dihydrofolate Reductase, HIV Reverse Transcriptase and Thermolysin. Target pharmacophores were defined through visual analysis of the data sets. The pharmacophore models produced were evaluated qualitatively through visual inspection and according to their ability to generate the target pharmacophores. Our results show that GASP and Catalyst outperformed DISCO at reproducing the five target pharmacophores.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12602956     DOI: 10.1023/a:1021954728347

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  36 in total

1.  Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding.

Authors:  J Ren; C Nichols; L E Bird; T Fujiwara; H Sugimoto; D I Stuart; D K Stammers
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

2.  High resolution structures of HIV-1 RT from four RT-inhibitor complexes.

Authors:  J Ren; R Esnouf; E Garman; D Somers; C Ross; I Kirby; J Keeling; G Darby; Y Jones; D Stuart
Journal:  Nat Struct Biol       Date:  1995-04

3.  Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Authors:  A L Hopkins; J Ren; R M Esnouf; B E Willcox; E Y Jones; C Ross; T Miyasaka; R T Walker; H Tanaka; D K Stammers; D I Stuart
Journal:  J Med Chem       Date:  1996-04-12       Impact factor: 7.446

4.  X-ray and spectrophotometric studies of the binding of proflavin to the S1 specificity pocket of human alpha-thrombin.

Authors:  E Conti; C Rivetti; A Wonacott; P Brick
Journal:  FEBS Lett       Date:  1998-03-27       Impact factor: 4.124

5.  Identification of common functional configurations among molecules.

Authors:  D Barnum; J Greene; A Smellie; P Sprague
Journal:  J Chem Inf Comput Sci       Date:  1996 May-Jun

6.  Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.

Authors:  J F Davies; T J Delcamp; N J Prendergast; V A Ashford; J H Freisheim; J Kraut
Journal:  Biochemistry       Date:  1990-10-09       Impact factor: 3.162

7.  Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors.

Authors:  S T Davis; B G Benson; H N Bramson; D E Chapman; S H Dickerson; K M Dold; D J Eberwein; M Edelstein; S V Frye; R T Gampe; R J Griffin; P A Harris; A M Hassell; W D Holmes; R N Hunter; V B Knick; K Lackey; B Lovejoy; M J Luzzio; D Murray; P Parker; W J Rocque; L Shewchuk; J M Veal; D H Walker; L F Kuyper
Journal:  Science       Date:  2001-01-05       Impact factor: 47.728

8.  Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.

Authors:  A Gangjee; A P Vidwans; A Vasudevan; S F Queener; R L Kisliuk; V Cody; R Li; N Galitsky; J R Luft; W Pangborn
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

9.  Redetermination and refinement of the complex of benzylsuccinic acid with thermolysin and its relation to the complex with carboxypeptidase A.

Authors:  A C Hausrath; B W Matthews
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

10.  Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.

Authors:  Y Hsiou; K Das; J Ding; A D Clark; J P Kleim; M Rösner; I Winkler; G Riess; S H Hughes; E Arnold
Journal:  J Mol Biol       Date:  1998-11-27       Impact factor: 5.469

View more
  20 in total

1.  Generation of multiple pharmacophore hypotheses using multiobjective optimisation techniques.

Authors:  Simon J Cottrell; Valerie J Gillet; Robin Taylor; David J Wilton
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

2.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.

Authors:  Steven L Dixon; Alexander M Smondyrev; Eric H Knoll; Shashidhar N Rao; David E Shaw; Richard A Friesner
Journal:  J Comput Aided Mol Des       Date:  2006-11-24       Impact factor: 3.686

3.  Incorporating partial matches within multi-objective pharmacophore identification.

Authors:  Simon J Cottrell; Valerie J Gillet; Robin Taylor
Journal:  J Comput Aided Mol Des       Date:  2007-01-04       Impact factor: 3.686

4.  A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.

Authors:  Nidhi Singh; Gwénaël Chevé; David M Ferguson; Christopher R McCurdy
Journal:  J Comput Aided Mol Des       Date:  2006-09-29       Impact factor: 3.686

5.  GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D.

Authors:  Nicola J Richmond; Charlene A Abrams; Philippa R N Wolohan; Edmond Abrahamian; Peter Willett; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2006-10-19       Impact factor: 3.686

Review 6.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

7.  Identification of potential ACAT-2 selective inhibitors using pharmacophore, SVM and SVR from Chinese herbs.

Authors:  Lian-Sheng Qiao; Xian-Bao Zhang; Lu-di Jiang; Yan-Ling Zhang; Gong-Yu Li
Journal:  Mol Divers       Date:  2016-06-21       Impact factor: 2.943

8.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism.

Authors:  Philip Prathipati; Anil K Saxena
Journal:  J Comput Aided Mol Des       Date:  2005-02       Impact factor: 3.686

10.  Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; Benjamin Z Stanton; Jotaro Igarashi; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.